Artivion is a US cardiac and vascular surgery company focused on aortic disease. It develops and markets innovative medical devices, including aortic stents and stent grafts, prosthetic heart valves, and cryopreserved cardiac and vascular allografts.
Artivion operates in the medical device sector, with a specific focus on the cardiovascular market. Artivion is a leader in the development of innovative aortic-centric technologies, and its products are used in hospitals and clinics around the world.
Track the share price of AORT by adding it to your eToro watchlist.